NADINE BELTRAN: Open Payments
NPI 1518316421 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$143 in 5 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $42 · 2025 $143
Food & beverage: $143
| Company | Payments | Amount |
|---|---|---|
| Almirall LLC | 1 | $40 |
| LEO Pharma Inc. | 1 | $33 |
| Incyte Corporation | 1 | $27 |
| REVANCE THERAPEUTICS, INC. | 1 | $23 |
| Arcutis Biotherapeutics, Inc. | 1 | $20 |
Products named: Klisyri, ANZUPGO, OPZELURA, DAXXIFY, Zoryve.
Industry payments across CA — which companies pay providers there.
